Sponsor or institution
Clinical trials and research at Arcagy/ Gineco Group
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Arcagy/ Gineco Group that are recruiting, at sites in 7 countries (most in France (4), Italy (3), Spain (2)). By phase: Phase 2 (2), Phase 2/3 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 7Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Adjusting chemotherapy for patients with poor prognosis ovarian cancer | Phase 3 | Angers and 75 other locations | Recruiting | Jun 26, 2024 |
| Niraparib and Bevacizumab for Ovarian Cancer Treatment | Phase 2 | Angers and 87 other locations | Recruiting | Jan 11, 2022 |
| Combining Pembrolizumab with standard chemotherapy for small cell ovarian carcinoma | Phase 2 | Angers and 12 other locations | Recruiting | Oct 26, 2020 |
| Niraparib alone or with dostarlimab for recurrent ovarian or uterine carcinosarcoma | Phase 2/3 | Angers and 35 other locations | Recruiting | Aug 29, 2018 |
All recruiting trials (4)
-
Adjusting chemotherapy for patients with poor prognosis ovarian cancer
This study is testing if changing the chemotherapy plan for people with advanced ovarian cancer can help them live longer compared to sticking with the usual treatment.
-
Niraparib and Bevacizumab for Ovarian Cancer Treatment
This study is testing whether a new combination of two medications can help women with newly diagnosed ovarian cancer feel better after their surgery and chemotherapy.
-
Combining Pembrolizumab with standard chemotherapy for small cell ovarian carcinoma
This study is testing if adding the immunotherapy drug Pembrolizumab to standard chemotherapy can help people aged 12 and older with small cell ovarian carcinoma feel better and live longer.
-
Niraparib alone or with dostarlimab for recurrent ovarian or uterine carcinosarcoma
This trial tests whether the oral drug niraparib, alone or combined with the immunotherapy dostarlimab, helps people with recurrent or metastatic ovarian or uterine carcinosarcoma.
Quick answers
How many clinical trials run by Arcagy/ Gineco Group are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in France (4 trials), Italy (3 trials), Spain (2 trials), Japan (2 trials), Singapore (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 2/3: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.